End-Stage Renal Disease (ESRD) Overview

Save information for later
Sign Up

Learn About End-Stage Renal Disease (ESRD)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top End-Stage Renal Disease (ESRD) Local Doctors?
Addiction Medicine
Addiction Medicine
1001 9th Ave, Suite 2, 
Brackenridge, PA 
 1.1 mi

Jamal Aljari is an Addiction Medicine provider in Brackenridge, Pennsylvania. Dr. Aljari and is rated as an Advanced provider by MediFind in the treatment of End-Stage Renal Disease (ESRD). His top areas of expertise are End-Stage Renal Disease (ESRD), Omsk Hemorrhagic Fever, Vitamin D Deficiency, and Opioid Use Disorder.

Vascular Surgery | General Surgery
Vascular Surgery | General Surgery

Allegheny Clinic

1600 Pacific Ave, Suite 9, 
Natrona Heights, PA 
 2.4 mi

Carlos Rosales is a Vascular Surgeon and a General Surgeon in Natrona Heights, Pennsylvania. Dr. Rosales and is rated as an Advanced provider by MediFind in the treatment of End-Stage Renal Disease (ESRD). His top areas of expertise are Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm, Arterial Insufficiency, Peptic Ulcer, and Carotid Artery Surgery.

 
 
 
 
Learn about our expert tiers
Learn More
251 7th St, Ste C204, 
New Kensington, PA 
 2.7 mi

Darius Saghafi is a Nephrologist in New Kensington, Pennsylvania. Dr. Saghafi and is rated as an Advanced provider by MediFind in the treatment of End-Stage Renal Disease (ESRD). His top areas of expertise are Poststreptococcal Glomerulonephritis, Acute Kidney Failure, Fanconi Bickel Syndrome, and Lysinuric Protein Intolerance.

What are the latest End-Stage Renal Disease (ESRD) Clinical Trials?
An Open-Label, Single-Dose, Phase 1 Study to Evaluate the Pharmacokinetics and Safety of BMS-986278 in Participants With Normal Renal Function, Participants With Severe Renal Impairment, and Participants With End-Stage Renal Disease on Intermittent Hemodialysis

Summary: The purpose of this study is to assess the effect of severe renal impairment (RI) and end-stage renal disease (ESRD) with intermittent hemodialysis (IHD) on the pharmacokinetics and safety of BMS-986278. This study plans to use a staged design based on RI severity.

Match to trials
Find the right clinical trials for you in under a minute
Get started